Drug Screening Market Forecast 2023-2027
The drug screening market size is estimated to grow by USD 6,659.87 million at a CAGR (Compound Annual Growth Rate) of 16.97% between 2022 and 2027. The growth of the market depends on several factors, including advancements in drug screening technologies, increased strategic developments, and stringent workplace safety regulations
What will be the Size of the Market During the Forecast Period?
To learn more about this report, View Report Sample
Market Dynamics
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Driver
Advancements in drug screening technologies is notably driving the market growth. Due to the improvements in technology the global drugs screening market showing growth. Factors such as the sensitivity, specificity, and effectiveness of drugs have increased innovation and advancements in testing equipment and procedures. For example, the development of fast tests based on immunoassays enables speedy on-site screening and provides immediate findings.
moreover, due to the incorporation of cutting-edge analytical techniques such as liquid chromatography-mass spectrometry (LC-MS) identification and quantification of drug compounds are made possible. Because of these developments, dependence on drugs enables better identification of a variety of substances and their metabolites. Because of the utilization of microfluidic devices, biosensors, and lab-on-a-chip platforms, results in improved sensitivity, lower sample volumes, and quicker turnaround times in processes. Hence, advancements in technologies are a driver that will boost the growth of the market in focus during the forecast period.
Significant Trends
Integration of artificial intelligence (AI) and machine learning (ML) in drug screening is the primary trend in the market. Drug screening procedures are being improved in terms of precision, effectiveness, and dependability by utilizing AI and ML algorithms. Due to these systems, we can examine enormous volumes of data and spot trends that might point to drug use, producing more accurate results.
Moreover, machine learning models can be trained to identify new medication trends and modify testing procedures accordingly. Additionally, Artificial intelligence-powered software can easily simplify data administration and reporting, optimizing workflow generally and the decision-making process is getting smoother with AI. Hence, the integration of AI and ML is a trend that is expected to drive the growth of the market trends during the forecast period.
Major Challenge
The development of alternative testing methods is a major challenge in the market. Traditional urine and blood testing techniques are having risk of losing their significance. As compared with alternative techniques, including sweat patch testing, oral fluid testing, and hair follicle testing, each has unique benefits and drawbacks. This makes it challenging for companies that conduct drug testing to alter their practices
moreover, it challenges companies to make the necessary investments in alternative technology to satisfy shifting consumer preferences. Furthermore, modifications to current regulatory frameworks and standardization procedures might be needed to accommodate the use of alternative testing methodologies. For example, compared with urine or blood testing, hair follicle testing offers a longer detection window for drug usage but calls for specialized equipment and training. Hence, the development of alternative testing methods might negatively impact the adoption of products and solutions, which will hinder market growth during the forecast period.
Key Customer Landscape
The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Who are the Major Companies?
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Alfa Scientific Designs Inc: The company offers drug screening such as drug testing which provides saliva, urine CUPs, and single-drug urine tests.
The market growth and forecasting report also includes detailed analyses of the competitive landscape of the market and information about 20 market Companies, including:
- Abbott Laboratories
- bioMerieux SA
- Bio Rad Laboratories Inc.
- Bombardier Recreational Products Inc.
- Dragerwerk AG and Co. KGaA
- F. Hoffmann La Roche Ltd.
- Healgen Scientific, LLC
- Laboratory Corp. of America Holdings
- Lifeloc Technologies Inc.
- LINEAR CHEMICALS S.L.U
- Lochness Medical Supplies Inc.
- Omega Laboratories, Inc.
- OraSure Technologies Inc.
- Premier Biotech Inc.
- Psychemedics Corp.
- Quest Diagnostics Inc.
- Shimadzu Corp.
- Siemens AG
- Thermo Fisher Scientific Inc.
Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
Market Segmentation
The market share growth by the drug screening products segment will be significant during the forecast period. The global market for products includes test kits, analyzers, and consumables, and these items are widely used for the purpose of drug screening. The demand for these items is steadily expanding owing to rising drug misuse, strict restrictions, and concerns about worker safety. For instance, drug screening is necessary in the transportation, healthcare, and construction sectors to verify compliance with rules and maintain a secure workplace.
Get a glance at the market contribution of various segments View the PDF Sample
The drug screening products segment showed a gradual increase in the market share of USD 2,049.04 million in 2017 and continued to grow by 2021. The need for products has increased because of technological developments that have developed more reliable solutions. However, there are challenges due to fierce rivalry, pricing constraints, and the requirement for constant product innovation. Despite these challenges, the market is anticipated to develop during the forecast period due to the rising demand for products, particularly in the healthcare, workplace, and sports sectors.
Regional Analysis
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. stringent regulations and wider drug testing programs in the healthcare, transportation, and sporting sectors in the region are driving the industry. Factors that drove the market's expansion in 2022 due to the increasing incidence of drug abuse and demand for workplace safety.
Moreover, because of the opioid crisis in North America, Quest Diagnostics developed a new drug testing panel in June 2021 that was built to detect fentanyl analogs. In addition, technological developments, including the introduction of quick point-of-care testing tools and the use of laboratory information management systems (LIMS) for quick sample processing, were fueling market growth. The regional market is expected to witness significant growth during the forecast period.
Market Analyst Overview
The Market experiences steady growth driven by rising drug and alcohol consumption, highlighted in the World Drug Report 2021. Research studies, industry trend analyses, and pricing assessments inform key stakeholders about market dynamics. Regulatory approvals shape the landscape amidst stringent laws and prohibitions on workplace drug testing, notably in Islamic countries like Colombia, Argentina, and Chile. Drug screening products and services cater to diverse needs, including pre-employment testing, amid concerns over impaired driving and illicit drug use disorders. However, concerns over employee privacy and regulatory restraints, particularly in regions like Poland and the Czech Republic, pose challenges to market expansion.
Segment Overview
The Market forecasting report covers market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- Type Outlook (USD Million, 2017 - 2027)
- Drug screening products
- Drug screening services
- Application Outlook (USD Million, 2017 - 2027)
- Urine samples
- Breath samples
- Hair and blood samples
- Oral fluid samples
- Region Outlook (USD Million, 2017 - 2027)
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
Market Scope
|
Market Report Coverage
|
Details
|
Page number
|
152
|
Base year
|
2022
|
Historic period
|
2017-2021
|
Forecast period
|
2023-2027
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 16.97%
|
Market growth 2023-2027
|
USD 6,659.87 million
|
Market structure
|
Fragmented
|
YoY growth 2022-2023(%)
|
15.64
|
Regional analysis
|
North America, Europe, Asia, and Rest of World (ROW)
|
Performing market contribution
|
North America at 44%
|
Key countries
|
US, Canada, Germany, China, and Japan
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled
|
Abbott Laboratories, Alfa Scientific Designs Inc, bioMerieux SA, Bio Rad Laboratories Inc., Bombardier Recreational Products Inc., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Healgen Scientific, LLC, Laboratory Corp. of America Holdings, Lifeloc Technologies Inc., LINEAR CHEMICALS S.L.U, Lochness Medical Supplies Inc., Omega Laboratories, Inc., OraSure Technologies Inc., Premier Biotech Inc., Psychemedics Corp., Quest Diagnostics Inc., Shimadzu Corp., Siemens AG, and Thermo Fisher Scientific Inc.
|
Market dynamics
|
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
|
Customization purview
|
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
|
View PDF Sample
What are the Key Data Covered in this Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the market between 2023 and 2027
- Precise estimation of the market and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about Companies
- Comprehensive analysis of factors that will challenge the growth of market Companies
We can help! Our analysts can customize this market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global drug screening market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global drug screening market 2017 - 2021 ($ million)
- 4.2 Type Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
- 4.3 Application Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
- 6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
- 6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type
- 6.3 Drug screening products - Market size and forecast 2022-2027
- Exhibit 34: Chart on Drug screening products - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Drug screening products - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Drug screening products - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Drug screening products - Year-over-year growth 2022-2027 (%)
- 6.4 Drug screening services - Market size and forecast 2022-2027
- Exhibit 38: Chart on Drug screening services - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Drug screening services - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Drug screening services - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Drug screening services - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ million)
- Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
- 7.1 Market segments
- Exhibit 44: Chart on Application - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
- 7.2 Comparison by Application
- Exhibit 46: Chart on Comparison by Application
- Exhibit 47: Data Table on Comparison by Application
- 7.3 Urine samples - Market size and forecast 2022-2027
- Exhibit 48: Chart on Urine samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Urine samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Urine samples - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Urine samples - Year-over-year growth 2022-2027 (%)
- 7.4 Breath samples - Market size and forecast 2022-2027
- Exhibit 52: Chart on Breath samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Breath samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Breath samples - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Breath samples - Year-over-year growth 2022-2027 (%)
- 7.5 Hair and blood samples - Market size and forecast 2022-2027
- Exhibit 56: Chart on Hair and blood samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Hair and blood samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Hair and blood samples - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Hair and blood samples - Year-over-year growth 2022-2027 (%)
- 7.6 Oral fluid samples - Market size and forecast 2022-2027
- Exhibit 60: Chart on Oral fluid samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Data Table on Oral fluid samples - Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Chart on Oral fluid samples - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on Oral fluid samples - Year-over-year growth 2022-2027 (%)
- 7.7 Market opportunity by Application
- Exhibit 64: Market opportunity by Application ($ million)
- Exhibit 65: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2022-2027 (%)
- Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Germany - Market size and forecast 2022-2027
- Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.9 China - Market size and forecast 2022-2027
- Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.10 Japan - Market size and forecast 2022-2027
- Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- 9.11 Canada - Market size and forecast 2022-2027
- Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2022 and 2027
11 Vendor Landscape
- 11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 112: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 113: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification
- 12.3 Abbott Laboratories
- Exhibit 115: Abbott Laboratories - Overview
- Exhibit 116: Abbott Laboratories - Business segments
- Exhibit 117: Abbott Laboratories - Key news
- Exhibit 118: Abbott Laboratories - Key offerings
- Exhibit 119: Abbott Laboratories - Segment focus
- 12.4 Alfa Scientific Designs Inc
- Exhibit 120: Alfa Scientific Designs Inc - Overview
- Exhibit 121: Alfa Scientific Designs Inc - Product / Service
- Exhibit 122: Alfa Scientific Designs Inc - Key offerings
- 12.5 Dragerwerk AG and Co. KGaA
- Exhibit 123: Dragerwerk AG and Co. KGaA - Overview
- Exhibit 124: Dragerwerk AG and Co. KGaA - Business segments
- Exhibit 125: Dragerwerk AG and Co. KGaA - Key offerings
- Exhibit 126: Dragerwerk AG and Co. KGaA - Segment focus
- 12.6 F. Hoffmann La Roche Ltd.
- Exhibit 127: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 128: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 129: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 130: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 131: F. Hoffmann La Roche Ltd. - Segment focus
- 12.7 Healgen Scientific, LLC
- Exhibit 132: Healgen Scientific, LLC - Overview
- Exhibit 133: Healgen Scientific, LLC - Product / Service
- Exhibit 134: Healgen Scientific, LLC - Key offerings
- 12.8 Laboratory Corp. of America Holdings
- Exhibit 135: Laboratory Corp. of America Holdings - Overview
- Exhibit 136: Laboratory Corp. of America Holdings - Business segments
- Exhibit 137: Laboratory Corp. of America Holdings - Key news
- Exhibit 138: Laboratory Corp. of America Holdings - Key offerings
- Exhibit 139: Laboratory Corp. of America Holdings - Segment focus
- 12.9 Lifeloc Technologies Inc.
- Exhibit 140: Lifeloc Technologies Inc. - Overview
- Exhibit 141: Lifeloc Technologies Inc. - Business segments
- Exhibit 142: Lifeloc Technologies Inc. - Key offerings
- Exhibit 143: Lifeloc Technologies Inc. - Segment focus
- 12.10 LINEAR CHEMICALS S.L.U
- Exhibit 144: LINEAR CHEMICALS S.L.U - Overview
- Exhibit 145: LINEAR CHEMICALS S.L.U - Product / Service
- Exhibit 146: LINEAR CHEMICALS S.L.U - Key offerings
- 12.11 Lochness Medical Supplies Inc.
- Exhibit 147: Lochness Medical Supplies Inc. - Overview
- Exhibit 148: Lochness Medical Supplies Inc. - Product / Service
- Exhibit 149: Lochness Medical Supplies Inc. - Key offerings
- 12.12 Omega Laboratories, Inc.
- Exhibit 150: Omega Laboratories, Inc. - Overview
- Exhibit 151: Omega Laboratories, Inc. - Product / Service
- Exhibit 152: Omega Laboratories, Inc. - Key offerings
- 12.13 OraSure Technologies Inc.
- Exhibit 153: OraSure Technologies Inc. - Overview
- Exhibit 154: OraSure Technologies Inc. - Business segments
- Exhibit 155: OraSure Technologies Inc. - Key offerings
- Exhibit 156: OraSure Technologies Inc. - Segment focus
- 12.14 Premier Biotech Inc.
- Exhibit 157: Premier Biotech Inc. - Overview
- Exhibit 158: Premier Biotech Inc. - Product / Service
- Exhibit 159: Premier Biotech Inc. - Key offerings
- 12.15 Psychemedics Corp.
- Exhibit 160: Psychemedics Corp. - Overview
- Exhibit 161: Psychemedics Corp. - Product / Service
- Exhibit 162: Psychemedics Corp. - Key offerings
- 12.16 Quest Diagnostics Inc.
- Exhibit 163: Quest Diagnostics Inc. - Overview
- Exhibit 164: Quest Diagnostics Inc. - Business segments
- Exhibit 165: Quest Diagnostics Inc. - Key offerings
- Exhibit 166: Quest Diagnostics Inc. - Segment focus
- 12.17 Thermo Fisher Scientific Inc.
- Exhibit 167: Thermo Fisher Scientific Inc. - Overview
- Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 169: Thermo Fisher Scientific Inc. - Key news
- Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.2 Inclusions and exclusions checklist
- Exhibit 172: Inclusions checklist
- Exhibit 173: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 174: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 175: Research methodology
- Exhibit 176: Validation techniques employed for market sizing
- Exhibit 177: Information sources
- 13.5 List of abbreviations
- Exhibit 178: List of abbreviations